180 Life Sciences Corp (ATNF)
2.02
+0.03
(+1.51%)
USD |
NASDAQ |
May 02, 11:32
180 Life Sciences Max Drawdown (5Y): 99.97% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.97% |
| March 31, 2024 | 99.96% |
| February 29, 2024 | 99.93% |
| January 31, 2024 | 99.93% |
| December 31, 2023 | 99.93% |
| November 30, 2023 | 99.89% |
| October 31, 2023 | 99.82% |
| September 30, 2023 | 99.78% |
| August 31, 2023 | 99.77% |
| July 31, 2023 | 99.62% |
| June 30, 2023 | 99.60% |
| May 31, 2023 | 99.60% |
| April 30, 2023 | 99.55% |
| March 31, 2023 | 99.48% |
| February 28, 2023 | 99.48% |
| January 31, 2023 | 99.48% |
| December 31, 2022 | 99.48% |
| November 30, 2022 | 97.08% |
| October 31, 2022 | 96.24% |
| September 30, 2022 | 94.45% |
| August 31, 2022 | 93.23% |
| July 31, 2022 | 93.23% |
| June 30, 2022 | 93.23% |
| May 31, 2022 | 91.24% |
| April 30, 2022 | 87.65% |
| Date | Value |
|---|---|
| March 31, 2022 | 80.87% |
| February 28, 2022 | 80.87% |
| January 31, 2022 | 80.87% |
| December 31, 2021 | 80.87% |
| November 30, 2021 | 80.87% |
| October 31, 2021 | 80.87% |
| September 30, 2021 | 80.87% |
| August 31, 2021 | 80.87% |
| July 31, 2021 | 80.87% |
| June 30, 2021 | 80.87% |
| May 31, 2021 | 80.87% |
| April 30, 2021 | 80.87% |
| March 31, 2021 | 80.87% |
| February 28, 2021 | 80.87% |
| January 31, 2021 | 80.87% |
| December 31, 2020 | 80.87% |
| November 30, 2020 | 80.87% |
| October 31, 2020 | 27.94% |
| September 30, 2020 | 6.72% |
| August 31, 2020 | 6.72% |
| July 31, 2020 | 6.72% |
| June 30, 2020 | 6.72% |
| May 31, 2020 | 6.72% |
| April 30, 2020 | 6.72% |
| March 31, 2020 | 6.72% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
1.53%
Minimum
May 2019
99.97%
Maximum
Apr 2024
65.26%
Average
80.87%
Median
Nov 2020
Max Drawdown (5Y) Benchmarks
| Seelos Therapeutics Inc | 99.93% |
| Altimmune Inc | 99.85% |
| GT Biopharma Inc | 100.00% |
| Outlook Therapeutics Inc | 98.82% |
| MAIA Biotechnology Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -84.51 |
| Beta (5Y) | 0.424 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.8% |
| Historical Sharpe Ratio (5Y) | -0.7914 |
| Historical Sortino (5Y) | -1.267 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 46.27% |